Literature DB >> 9625097

Plasma lipoproteins as carriers of phylloquinone (vitamin K1) in humans.

S Lamon-Fava1, J A Sadowski, K W Davidson, M E O'Brien, J R McNamara, E J Schaefer.   

Abstract

The purpose of this study was to characterize the absorption and transport of phylloquinone (vitamin K1) by plasma lipoproteins. Twenty-six healthy subjects (11 men and 15 women) aged 20-78 y received phylloquinone in the amount of either 1.43 or 50 microg/kg body wt orally with a fat-rich meal containing 1.0 g/kg body wt of fat, carbohydrate, and protein and 7.0 mg cholesterol/kg body wt. Blood was obtained at baseline (0 h) and 3, 6, 9, and 12 h after the meal for the measurement of plasma lipid and phylloquinone concentrations in plasma and lipoprotein subfractions. In both groups of subjects, triacylglycerol concentrations peaked after 3 h in plasma and in the triacylglycerol-rich lipoprotein fraction, composed of chylomicrons and VLDLs. Plasma phylloquinone concentrations peaked at 6 h. At baseline and during the postprandial phase, > 53% of plasma phylloquinone was carried by the triacylglycerol-rich lipoprotein fraction. In 9 of the 11 subjects supplemented with 50 microg phylloquinone/kg, plasma lipoproteins were isolated by sequential ultracentrifugation. In these subjects the fraction of plasma phylloquinone carried by LDLs and by HDLs increased progressively from 3% and 4% at 3 h to 14% and 11% at 12 h, respectively. Our data indicate that whereas triacylglycerol-rich lipoproteins are the major carriers of phylloquinone, LDL and HDL may carry small fractions of this vitamin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9625097     DOI: 10.1093/ajcn/67.6.1226

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  29 in total

Review 1.  Pharmacogenetics of target genes across the warfarin pharmacological pathway.

Authors:  Suman Lal; Srinivasa Rao Jada; Xiaoqiang Xiang; Wan-Teck Lim; Edmund J D Lee; Balram Chowbay
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Inhibition of purified pig and human liver retinyl ester hydrolase by pharmacologic agents.

Authors:  R Schindler
Journal:  Lipids       Date:  2001-05       Impact factor: 1.880

3.  The UBIAD1 prenyltransferase links menaquinone-4 [corrected] synthesis to cholesterol metabolic enzymes.

Authors:  Michael L Nickerson; Allen D Bosley; Jayne S Weiss; Brittany N Kostiha; Yoshihisa Hirota; Wolfgang Brandt; Dominic Esposito; Shigeru Kinoshita; Ludger Wessjohann; Scott G Morham; Thorkell Andresson; Howard S Kruth; Toshio Okano; Michael Dean
Journal:  Hum Mutat       Date:  2012-11-27       Impact factor: 4.878

4.  Associations between vitamin K status and haemostatic and inflammatory biomarkers in community-dwelling adults. The Multi-Ethnic Study of Atherosclerosis.

Authors:  M K Shea; M Cushman; S L Booth; G L Burke; H Chen; S B Kritchevsky
Journal:  Thromb Haemost       Date:  2014-05-22       Impact factor: 5.249

5.  The bladder tumor suppressor protein TERE1 (UBIAD1) modulates cell cholesterol: implications for tumor progression.

Authors:  William J Fredericks; Terry McGarvey; Huiyi Wang; Priti Lal; Raghunath Puthiyaveettil; John Tomaszewski; Jorge Sepulveda; Ed Labelle; Jayne S Weiss; Michael L Nickerson; Howard S Kruth; Wolfgang Brandt; Ludger A Wessjohann; S Bruce Malkowicz
Journal:  DNA Cell Biol       Date:  2011-07-08       Impact factor: 3.311

6.  Fecal concentrations of bacterially derived vitamin K forms are associated with gut microbiota composition but not plasma or fecal cytokine concentrations in healthy adults.

Authors:  J Philip Karl; Mohsen Meydani; Junaidah B Barnett; Sally M Vanegas; Kathryn Barger; Xueyan Fu; Barry Goldin; Anne Kane; Helen Rasmussen; Pajau Vangay; Dan Knights; Satya S Jonnalagadda; Edward Saltzman; Susan B Roberts; Simin N Meydani; Sarah L Booth
Journal:  Am J Clin Nutr       Date:  2017-08-16       Impact factor: 7.045

7.  Epigenome-wide association study reveals a molecular signature of response to phylloquinone (vitamin K1) supplementation.

Authors:  Kenneth Westerman; Jennifer M Kelly; José M Ordovás; Sarah L Booth; Dawn L DeMeo
Journal:  Epigenetics       Date:  2020-03-05       Impact factor: 4.528

Review 8.  Warfarin therapy: in need of improvement after all these years.

Authors:  Stephen E Kimmel
Journal:  Expert Opin Pharmacother       Date:  2008-04       Impact factor: 3.889

9.  Association between circulating vitamin K1 and coronary calcium progression in community-dwelling adults: the Multi-Ethnic Study of Atherosclerosis.

Authors:  M Kyla Shea; Sarah L Booth; Michael E Miller; Gregory L Burke; Haiying Chen; Mary Cushman; Russell P Tracy; Stephen B Kritchevsky
Journal:  Am J Clin Nutr       Date:  2013-05-29       Impact factor: 7.045

10.  The effect of different meals on the absorption of stable isotope-labelled phylloquinone.

Authors:  Kerry S Jones; Les J C Bluck; Laura Y Wang; Alison M Stephen; Celia J Prynne; W Andy Coward
Journal:  Br J Nutr       Date:  2009-06-19       Impact factor: 3.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.